STAAR SURGICAL COMPANY

NASDAQ: STAA (STAAR Surgical Company)

最近更新时间: 16 Sep, 8:44PM

27.23

-0.44 (-1.59%)

前收盘价格 27.67
收盘价格 27.57
成交量 863,332
平均成交量 (3个月) 1,574,314
市值 1,349,328,128
预期市盈率 (P/E Forward) 62.50
价格/销量 (P/S) 6.03
股市价格/股市净资产 (P/B) 4.02
52周波幅
13.50 (-50%) — 38.60 (41%)
利润日期 29 Oct 2025
营业毛利率 -25.46%
营业利益率 (TTM) -81.43%
稀释每股收益 (EPS TTM) -1.44
季度收入增长率 (YOY) -44.90%
季度盈利增长率 (YOY) 107.20%
总债务/股东权益 (D/E MRQ) 10.48%
流动比率 (MRQ) 4.78
营业现金流 (OCF TTM) -11.69 M
杠杆自由现金流 (LFCF TTM) 10.73 M
资产报酬率 (ROA TTM) -5.90%
股东权益报酬率 (ROE TTM) -19.14%

市场趋势

短期 中期
行业 Medical Instruments & Supplies (US) 混合的 混合的
Medical Instruments & Supplies (全球的) 混合的 看跌
股票 STAAR Surgical Company 看涨 看跌

AIStockmoo 评分

0.4
分析师共识 1.5
内部交易活动 NA
价格波动 -2.0
技术平均移动指标 2.5
技术振荡指标 -0.5
平均 0.38

相关股票

股票 市值 DY P/E(TTM) P/B
STAA 1 B - - 4.02
MMSI 5 B - 41.98 3.19
LMAT 2 B 0.80% 46.52 5.42
ATRC 2 B - - 3.77
AZTA 1 B - - 0.790
PLSE 1 B - - 12.23

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

部门 Healthcare
行业 Medical Instruments & Supplies
投资方式 Small Growth
内部持股比例 0.64%
机构持股比例 109.43%

所有权

姓名 日期 持有股份
Resona Asset Management Co.,Ltd. 30 Jun 2025 2,421,836
Yunqi Capital Ltd 30 Jun 2025 2,411,288
52周波幅
13.50 (-50%) — 38.60 (41%)
目标价格波幅
18.00 (-33%) — 28.00 (2%)
28.00 (Canaccord Genuity, 2.83%) 保留
28.00 (Stifel, 2.83%) 保留
28.00 (Sidoti & Co., 2.83%) 保留
28.00 (2.83%)
18.00 (Mizuho, -33.90%) 保留
平均值 25.50 (-6.35%)
总计 4 保留
平均价格@调整类型 24.49
公司 日期 目标价格 调整类型 价格@调整类型
Stifel 07 Aug 2025 28.00 (2.83%) 保留 26.95
Canaccord Genuity 06 Aug 2025 28.00 (2.83%) 保留 26.90
Sidoti & Co. 05 Aug 2025 28.00 (2.83%) 保留 27.02
Mizuho 16 Jul 2025 18.00 (-33.90%) 保留 17.09

该时间范围内无数据。

日期 类型 细节
06 Oct 2025 公告 Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon
06 Oct 2025 公告 STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
06 Oct 2025 公告 STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
03 Oct 2025 公告 Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
30 Sep 2025 公告 Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
26 Sep 2025 公告 STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
24 Sep 2025 公告 Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon
22 Sep 2025 公告 STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received
22 Sep 2025 公告 Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
16 Sep 2025 公告 STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
02 Sep 2025 公告 STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger
05 Aug 2025 公告 STAA Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of STAAR Surgical to Alcon
05 Aug 2025 公告 Alcon Agrees to Acquire STAAR Surgical
31 Jul 2025 公告 STAAR Surgical to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票